Human Genomics and Genetic Diseases
A section of Genes (ISSN 2073-4425).
Section Information
The section “Human Genomics and Genetic Diseases” covers the basic and translational aspects of human genetic and genomic research, from fundamental molecular investigation, to preclinical animal models and clinical studies. In particular, this section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the diagnosis, treatment and prognosis of genetic disorders, and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics and bioinformatic tools to advance knowledge in human genetic diseases and their clinical management, or address legal and ethical issues. Some of the section specialty areas include, but are not limited to:
- Genetics of monogenic diseases and complex diseases; genotype–phenotype relationships
- Population genomics and genetic epidemiology
- Precision medicine; pharmacogenetics and pharmacogenomics
- Targeted genome editing; gene therapy and delivery systems; genetically-engineered cell therapy
- RNA and small nucleic acid based therapeutics
- Genetic testing and molecular diagnostics; biomarker development and application; genome-wide association studies
- Epigenetic therapy; cancer immunotherapy
- Developmental genetics; epigenetics and epigenomics
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- The Role of Centromeres in Genome Stability (Deadline: 31 May 2020)
- Genetic Basis of Psoriasis (Deadline: 15 June 2020)
- Genetic Aspects of Female Infertility (Deadline: 19 June 2020)
- Wnt Signaling in Development, Regeneration and Cancer (Deadline: 30 June 2020)
- Marfan Syndrome and Related Disorders: Genetic Basis, Molecular Mechanisms, and Genotype–Phenotype Correlations (Deadline: 30 June 2020)
- BARD1 in Cancer (Deadline: 30 June 2020)
- Genes and Biomarkers of Mood and Anxiety Disorders (Deadline: 30 June 2020)
- Colorectal Cancer Genetics, Epigenetics, and Emerging Therapies (Deadline: 10 July 2020)
- Genetic Basis of the Response to Cancer Immunotherapy (Deadline: 10 July 2020)
- The Value of Genetics in the Identification of Treatable Rare Diseases. The Paradigm of Inborn Errors of Metabolism (Deadline: 17 July 2020)
- Cellular Growth Control by TOR Signaling (Deadline: 30 July 2020)
- Genetic Perspectives in Thyroid Cancer (Deadline: 31 July 2020)
- Forensic Genetics and Genomics (Deadline: 31 July 2020)
- Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation (Deadline: 1 August 2020)
- Genetics of Psychiatric Disorders (Deadline: 31 August 2020)
- Mechanisms Governing ARF Levels (Deadline: 31 August 2020)
- Genetic Variability in Age-Related Complex Traits and Human Longevity (Deadline: 18 September 2020)
- Toxicogenomics and Human Health (Deadline: 20 September 2020)
- Genetics of Inherited Kidney Cancer (Deadline: 20 September 2020)
- Genetic Complexity of Hormone Sensitive Cancers (Deadline: 30 September 2020)
- Complex Genetic Loci, 2nd edition (Deadline: 15 October 2020)
- Zebrafish Animal Models (Deadline: 15 October 2020)
- Genetics in Ophthalmology (Deadline: 20 October 2020)
- Genetic Disorders of the TGFβ Signaling Family (Deadline: 25 October 2020)
- Sex/Gender Differences in Health from Omics Approaches (Deadline: 31 October 2020)
- Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy (Deadline: 31 October 2020)
- Genomic Fabric Remodeling in Neurological Disorders (Deadline: 31 October 2020)
- Host Genetics in Susceptibility to Infectious Diseases (Deadline: 1 November 2020)
- Genetic and Environmental Factors in Ageing and Age-Related Disease (Deadline: 15 November 2020)
- Contribution of Genetic Factors in Immune-Pathogenesis of Multiple Sclerosis (Deadline: 22 November 2020)
- Human Developmental Disability Genetics (Deadline: 30 November 2020)
- Genetic Research in Fetal Medicine (Deadline: 30 November 2020)
- Molecular Oncology–Unmask the True Nature of Cancer (Deadline: 10 December 2020)
- Genetics of Mitochondrial Diseases: From Laboratory to the Clinic (Deadline: 13 December 2020)
- Genetic Disease in Mediterranean Region (Deadline: 15 December 2020)
- Genomic Imprinting and the Regulation of Growth and Metabolism (Deadline: 15 December 2020)
- Cardiovascular Genetics (Deadline: 18 December 2020)
- Splicing: The New Frontier in Therapeutics (Deadline: 31 December 2020)
- Non-coding RNAs: Variety of Roles and Applications in Human Diseases (Deadline: 31 December 2020)
- Genetics and Genomics of Bladder Cancer (Deadline: 31 December 2020)
- Genetic and Genomic Tools for Personalized Treatment of Lung Cancer (Deadline: 8 January 2021)
- Genetic Basis of Sensory and Neurological Disorders (Deadline: 28 February 2021)
- MicroRNAs Applications in Cancer, Therapeutics and Related Toxicities (Deadline: 28 February 2021)
- Novel Mutations Identified in Combined Pituitary Hormone Deficiency (CPHD) (Deadline: 31 March 2021)
- Male Reproduction: Regulation, Differentiation and Epigenetics (Deadline: 31 March 2021)
- Genetics and Genomics of Erythrocytosis (Deadline: 30 April 2021)
